Shanghai Haishun New Pharmaceutical Packaging Co Ltd
HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. The company offers pharmaceuticals packaging products, including cold-form, tropical foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, composit… Read more
Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) - Total Assets
Latest total assets as of September 2025: CN¥2.87 Billion CNY
Based on the latest financial reports, Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) holds total assets worth CN¥2.87 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Total Assets Trend (2011–2024)
This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total assets of CN¥2.87 Billion consist of 38.8% current assets and 61.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.4% |
| Accounts Receivable | CN¥385.25 Million | 13.4% |
| Inventory | CN¥223.59 Million | 7.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥121.45 Million | 4.2% |
| Goodwill | CN¥4.46 Million | 0.2% |
Asset Composition Trend (2011–2024)
This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Haishun New Pharmaceutical Packaging Co Ltd's current assets represent 38.8% of total assets in 2024, a decrease from 51.1% in 2011.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2024, up from 9.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 8.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 13.4% of total assets.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Competitors by Total Assets
Key competitors of Shanghai Haishun New Pharmaceutical Packaging Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SAMRYOONG Co.Ltd
KQ:014970
|
Korea | ₩96.42 Billion |
|
Zhuhai Zhongfu Enterprise Co Ltd
SHE:000659
|
China | CN¥1.97 Billion |
|
Shin Hwa Silup
KO:001770
|
Korea | ₩84.01 Billion |
|
Huangshan Novel Co Ltd
SHE:002014
|
China | CN¥4.17 Billion |
|
Shenzhen Jinjia Color Printing Group Co Ltd
SHE:002191
|
China | CN¥8.43 Billion |
|
Export Packing
KO:002200
|
Korea | ₩347.30 Billion |
|
Xiamen Hexing Packaging Printing Co Ltd
SHE:002228
|
China | CN¥7.52 Billion |
|
Shenzhen Beauty Star Co Ltd
SHE:002243
|
China | CN¥16.63 Billion |
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Shanghai Haishun New Pharmaceutical Packaging Co Ltd generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Shanghai Haishun New Pharmaceutical Packaging Co Ltd generates $ 2.58 in net profit.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.62 | 2.76 | 1.27 |
| Quick Ratio | 2.11 | 2.24 | 1.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥700.46 Million | CN¥ 749.91 Million | CN¥ 117.16 Million |
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanghai Haishun New Pharmaceutical Packaging Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.85 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -3.4% |
| Total Assets | CN¥2.89 Billion |
| Market Capitalization | $191.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Haishun New Pharmaceutical Packaging Co Ltd's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shanghai Haishun New Pharmaceutical Packaging Co Ltd's assets decreased by 3.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2024)
The table below shows the annual total assets of Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.89 Billion | -3.38% |
| 2023-12-31 | CN¥2.99 Billion | +29.55% |
| 2022-12-31 | CN¥2.31 Billion | +1.82% |
| 2021-12-31 | CN¥2.26 Billion | +61.09% |
| 2020-12-31 | CN¥1.41 Billion | +13.82% |
| 2019-12-31 | CN¥1.23 Billion | +31.02% |
| 2018-12-31 | CN¥942.48 Million | +32.77% |
| 2017-12-31 | CN¥709.87 Million | +3.80% |
| 2016-12-31 | CN¥683.89 Million | +101.84% |
| 2015-12-31 | CN¥338.83 Million | +17.63% |
| 2014-12-31 | CN¥288.04 Million | +12.04% |
| 2013-12-31 | CN¥257.08 Million | +16.68% |
| 2012-12-31 | CN¥220.32 Million | +17.70% |
| 2011-12-31 | CN¥187.19 Million | -- |